Obamacare and the Future of Drug Innovation
Throughout the month of December, Coffee and Markets will be looking back at the most significant stories of 2010 with recap interviews from leading thinkers. In today’s edition, Ben Domenech interviews Avik Roy, a health care analyst on Wall Street and author of The Apothecary blog, about how Obamacare effects pharmaceutical innovation.
We’re brought to you as always by BigGovernment and Stephen Clouse and Associates. You can find our iTunes feed at CoffeeandMarkets.com. If you’d like to email us, you can do so at coffee[at]newledger.com. We hope you enjoy the show.